Cargando…
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease progression leads to joint deformity and associated loss of function, which significantly impacts the quality of life for sufferers and adds to losses in the labor force. In the past few decades, RA has attracted increase...
Autores principales: | Ding, Qian, Hu, Wei, Wang, Ran, Yang, Qinyan, Zhu, Menglin, Li, Meng, Cai, Jianghong, Rose, Peter, Mao, Jianchun, Zhu, Yi Zhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935929/ https://www.ncbi.nlm.nih.gov/pubmed/36797236 http://dx.doi.org/10.1038/s41392-023-01331-9 |
Ejemplares similares
-
STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway
por: Wang, Ran, et al.
Publicado: (2022) -
Neuron navigator 2 is a novel mediator of rheumatoid arthritis
por: Wang, Ran, et al.
Publicado: (2021) -
New Targets and Strategies for Rheumatoid Arthritis: From Signal Transduction to Epigenetic Aspect
por: Zhu, Menglin, et al.
Publicado: (2023) -
NAV2 positively modulates inflammatory response of fibroblast‐like synoviocytes through activating Wnt/β‐catenin signaling pathway in rheumatoid arthritis
por: Wang, Ran, et al.
Publicado: (2021) -
S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway
por: Wu, Wei-Jun, et al.
Publicado: (2016)